THYROID CARCINOMA

Clinical trials for THYROID CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new THYROID CARCINOMA trials appear

Sign up with your email to follow new studies for THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 2 Completed 4 Terminated 1

Experimental cancer pill targets Hard-to-Treat gene mutations

Disease control Terminated

This early study tested an experimental oral drug called IK-595 in people with advanced solid tumors that have specific RAS or RAF gene mutations. The goal was to check safety, dosing, and early signs of tumor shrinkage. The study was terminated before completion, so full results…

Matched conditions: THYROID CARCINOMA

Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control

Last updated Jun 26, 2026 19:17 UTC

THYROID CARCINOMA

Get alerted when new THYROID CARCINOMA trials appear

Experimental cancer pill targets Hard-to-Treat gene mutations